StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories construction in Progress ($M) ($M)

Form 10-K / 10-Q Supplemental Balance Sheet Footnote

QuarterlyAnnual
Latest, Q4 2025
2,567
Period ended Dec 31, 2025
Change on a year earlier
+3.2%
2,488 in Q4 2024
History
13 quarters
Since Q4 2013
Sources
12
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConstruction in Progress ($M) ($M)Year on yearSource
Q4 2025Dec 31, 20252,567+3.2%SEC Filing (0001628280-26-010185) ↗
Q4 2024Dec 31, 20242,488+20.5%SEC Filing (0001628280-26-010185) ↗
Q4 2023Dec 31, 20232,064+39.1%SEC Filing (0001628280-25-007110) ↗
Q4 2022Dec 31, 20221,484+13.8%SEC Filing (0001628280-24-005348) ↗
Q4 2021Dec 31, 20211,304-3.9%SEC Filing (0001628280-23-004026) ↗
Q4 2020Dec 31, 20201,357+22.3%SEC Filing (0001104659-22-025141) ↗
Q4 2019Dec 31, 20191,110+24.2%SEC Filing (0001104659-21-025751) ↗
Q4 2018Dec 31, 2018894+22.1%SEC Filing (0001104659-20-023904) ↗
Q4 2017Dec 31, 2017732-23.9%SEC Filing (0001047469-19-000624) ↗
Q4 2016Dec 31, 2016962+3.7%SEC Filing (0001047469-18-000856) ↗
Q4 2015Dec 31, 2015928+27.6%SEC Filing (0001047469-17-000744) ↗
Q4 2014Dec 31, 2014727-16.2%SEC Filing (0001047469-16-010246) ↗
Q4 2013Dec 31, 2013868–SEC Filing (0001047469-15-001377) ↗

Cite this data

StockData. (2026). Abbott Laboratories Construction in Progress ($M) ($M), quarterly Q4 2013–Q4 2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/xbrl-ppe-cip

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.